Market Place
Sourcing Support
All News #Library
Biotech
KaliVir & Roche Partner To Test VET3-TGI With Atezolizumab
19 Nov 2025 //
BUSINESSWIRE
KaliVir Completes 1st IV Cohort in STEALTH-001 Solid Tumor Study
01 Oct 2025 //
BUSINESSWIRE
KaliVir Completes First Cohort in STEALTH-001 Cancer Trial
20 May 2025 //
BUSINESSWIRE
KaliVir Immunotherapeutics Details Presentation at 2025 AACR Meet
25 Mar 2025 //
BUSINESSWIRE
KaliVir Immunotherapeutics Strengthens Portfolio with 3 New Patents
18 Nov 2024 //
BUSINESSWIRE
Matica Biotechnology Establishes CDMO Partnership with KaliVir
24 Oct 2024 //
BUSINESSWIRE
KaliVir Doses First Patient In VET3-TGI Phase 1/1b Trial
08 Oct 2024 //
BUSINESSWIRE
KaliVir Immunotherapeutics Appoints Schond Greenway as Chief Financial Officer
04 Sep 2024 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.